Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Natera Inc (NTRA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 619,779
  • Shares Outstanding, K 54,510
  • Annual Sales, $ 210,940 K
  • Annual Income, $ -136,310 K
  • 36-Month Beta 2.07
  • Price/Sales 2.94
  • Price/Cash Flow N/A
  • Price/Book N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.93 +6.31%
on 04/27/18
13.00 -10.62%
on 05/09/18
+0.61 (+5.54%)
since 04/25/18
3-Month
8.60 +35.12%
on 04/03/18
13.00 -10.62%
on 05/09/18
+2.37 (+25.62%)
since 02/23/18
52-Week
7.78 +49.36%
on 08/07/17
14.76 -21.27%
on 10/06/17
+1.30 (+12.60%)
since 05/25/17

Most Recent Stories

More News
Natera Reports First Quarter 2018 Financial Results

Natera, Inc. (NASDAQ: NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, today reported financial results for the first quarter ended March 31, 2018, and provided...

NTRA : 11.62 (+2.20%)
Natera Inc. Announces First Quarter 2018 Earnings Conference Call

Natera, (NASDAQ: NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, today announced that it will release results for its first quarter ended March 31, 2018,...

NTRA : 11.62 (+2.20%)
Natera to Present Successful Results at AACR from Bladder and Colon Cancer Studies

Natera (NASDAQ: NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, will present data demonstrating the ability of Signatera(TM) (Research Use Only) to monitor...

NTRA : 11.62 (+2.20%)
Natera To Present New Data at ACMG Annual Meeting

Natera (NASDAQ: NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, will present new data that demonstrate the value of its unique single nucleotide polymorphism...

NTRA : 11.62 (+2.20%)
Natera Appoints Paul R. Billings, M.D., Ph.D., as Chief Medical Officer

Natera (NASDAQ: NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA (cfDNA), has appointed Paul R. Billings, M.D., Ph.D., as Chief Medical Officer and Senior Vice-President...

NTRA : 11.62 (+2.20%)
Wired News - Thermo Fisher Scientific Disclosed Plans to Build State-of-the-Art Pharma Services Facility in Germany

Stock Monitor: Natera Post Earnings Reporting

NTRA : 11.62 (+2.20%)
TMO : 213.65 (-1.07%)
QIAGEN Ties Up With Natera, Boosts GeneReader NGS Platform

QIAGEN (QGEN) forges ahead with deals to strengthen the GeneReader NGS Platform.

NTRA : 11.62 (+2.20%)
ATHN : 153.19 (-0.17%)
BIO : 287.93 (-0.39%)
QGEN : 36.26 (-0.06%)
QIAGEN and Natera partner to develop cutting-edge genetic testing assays for use on QIAGEN's GeneReader NGS System

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA), a world leader in providing Sample to Insight molecular solutions, and Natera, Inc. (NASDAQ: NTRA), a leading developer of next-generation sequencing...

NTRA : 11.62 (+2.20%)
QGEN : 36.26 (-0.06%)
Natera's Genetic Tests Now Fully Integrated into Yale New Haven Health's Epic EMR System

Natera, Inc., (NASDAQ: NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, today announced that Yale New Haven Health has fully integrated the company's Panorama®...

NTRA : 11.62 (+2.20%)
Investor Expectations to Drive Momentum within Natera, IDEX, IDT, Northwest Bancshares, Koppers, and ConnectOne -- Discovering Underlying Factors of Influence

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Natera, Inc. (NASDAQ:NTRA),...

NTRA : 11.62 (+2.20%)
CNOB : 26.70 (+0.19%)
NWBI : 17.24 (+0.23%)
IDT : 5.46 (+1.87%)
IEX : 139.27 (-1.18%)
KOP : 40.05 (+0.12%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade NTRA with:

Business Summary

Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California.

See More

Key Turning Points

2nd Resistance Point 11.91
1st Resistance Point 11.76
Last Price 11.62
1st Support Level 11.42
2nd Support Level 11.23

See More

52-Week High 14.76
Fibonacci 61.8% 12.09
Last Price 11.62
Fibonacci 50% 11.27
Fibonacci 38.2% 10.45
52-Week Low 7.78

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar